Table 3 Correlation between the systolic blood pressure measured at the end of experiment and the peak intensity of each marker.

Fischer strain (Control,

Ubiquitin 8.5 kDa

0.627

< 0.0001

L-NAME, Losartan,

SM22 a 22.4 kDa

0.631

< 0.0001

2K-1C) (n = 71)

Ct fragment Filamin A

0.781

< 0.0001

Thymosin β 4 4.9 kDa

0.613

< 0.0001

Brown-Norway strain (control,

Ubiquitin 8.5 kDa

0.421

ns

L-NAME) (n = 41)

SM22 a 22.4 kDa

0.014

ns

Ct fragment Filamin A

0.324

ns

Thymosin β 4 4.9 kDa

0.448

ns

Fischer strain (Control,

Ubiquitin 8.5 kDa

0.83

< 0.0001

L-NAME) (n = 51)

SM22 a 22.4 kDa

0.771

< 0.0001

Ct fragment Filamin A

0.855

< 0.0001

Thymosin β 4 4.9 kDa

0.84

< 0.0001